EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined Single Gene Testing and Genome Sequencing as an Effective Diagnostic Approach for Anophthalmia and Microphthalmia Patients

Rabia Basharat iD, Kim Rodenburg iD, María Rodríguez-Hidalgo iD, Afeefa Jarral, Ehsan Ullah iD, Jordi Corominas, Christian Gilissen iD, Syeda Tatheer Zehra, Usman Hameed, Muhammad Ansar, Suzanne E de Bruijn iD

Genes · 01.08.2023 · 14 (8) · 1573

DOI: 10.3390/genes14081573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 01.08.2023. Verfasst von Rabia Basharat und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan. Hauptthemen laut MEDLINE: Anophthalmos, Microphthalmos, Eye Abnormalities. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Research Support Initiative Program (IRSIP) of the Higher Education Commission (HEC), European Union’s Horizon 2020 Research and Innovation Programme, Foundation Fighting Blindness (FFB).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anophthalmia and microphthalmia (A/M) are among the most severe congenital developmental eye disorders. Despite the advancements in genome screening technologies, more than half of A/M patients do not receive a molecular diagnosis. We included seven consanguineous families affected with A/M from Pakistani cohort and an unknown molecular basis. Single gene testing of FOXE3 was performed, followed by genome sequencing for unsolved probands in order to establish a genetic diagnosis for these families. All seven families were provided with a genetic diagnosis. The identified variants were all homozygous, classified as (likely) pathogenic and present in an A/M-associated gene. Targeted FOXE3 sequencing revealed two previously reported pathogenic FOXE3 variants in four families. In the remaining families, genome sequencing revealed a known pathogenic PXDN variant, a novel 13bp deletion in VSX2, and one novel deep intronic splice variant in PXDN. An in vitro splice assay was performed for the PXDN splice variant which revealed a severe splicing defect. Our study confirmed the utility of genome sequencing as a diagnostic tool for A/M-affected individuals. Furthermore, the identification of a novel deep intronic pathogenic variant in PXDN highlights the role of non-coding variants in A/M-disorders and the value of genome sequencing for the identification of this type of variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnophthalmosMicrophthalmosEye AbnormalitiesHumansChromosome MappingGenetic Testing

Stichwörter der Autor:innen

anophthalmiadeep intronic variantgenome sequencingmicrophthalmiatargeted gene sequencing

Autor:innen und Institutionen

  • Department of Biochemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan.
  • Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • Department of Neuroscience, Biodonostia Health Research Institute, 20014 Donostia-San Sebastián, Spain.
  • Department of Biotechnology, Mirpur University of Science and Technology (MUST), Mirpur 10250, AJK, Pakistan.
  • Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.

ORCID-Profile: Rabia Basharat, Kim Rodenburg, María Rodríguez-Hidalgo, Ehsan Ullah, Christian Gilissen, Suzanne E de Bruijn

Förderung

  • International Research Support Initiative Program (IRSIP) of the Higher Education Commission (HEC)
  • European Union’s Horizon 2020 Research and Innovation Programme
  • Foundation Fighting Blindness (FFB)
  • National Research Program for University
  • Higher Education Commission, Pakistan

Zitieren

APA

Basharat, R., Rodenburg, K., Rodríguez-Hidalgo, M., Jarral, A., Ullah, E., Corominas, J., Gilissen, C., Zehra, S. T., Hameed, U., Ansar, M., & de Bruijn, S. E. (2023). Combined Single Gene Testing and Genome Sequencing as an Effective Diagnostic Approach for Anophthalmia and Microphthalmia Patients. Genes, 14(8), 1573. https://doi.org/10.3390/genes14081573

Vancouver

Basharat R, Rodenburg K, Rodríguez-Hidalgo M, Jarral A, Ullah E, Corominas J, et al. Combined Single Gene Testing and Genome Sequencing as an Effective Diagnostic Approach for Anophthalmia and Microphthalmia Patients. Genes. 2023;14(8):1573. doi:10.3390/genes14081573

BibTeX
@article{Basharat2023,
  author = {Basharat, Rabia and Rodenburg, Kim and Rodríguez-Hidalgo, María and Jarral, Afeefa and Ullah, Ehsan and Corominas, Jordi and Gilissen, Christian and Zehra, Syeda Tatheer and Hameed, Usman and Ansar, Muhammad and de Bruijn, Suzanne E},
  title = {Combined Single Gene Testing and Genome Sequencing as an Effective Diagnostic Approach for Anophthalmia and Microphthalmia Patients},
  journal = {Genes},
  year = {2023},
  volume = {14},
  number = {8},
  pages = {1573},
  doi = {10.3390/genes14081573}
}
Kostenlos starten →